Newman Ann W, Byrn Stephen R
SSCI, West Lafayette, IN 47906, USA.
Drug Discov Today. 2003 Oct 1;8(19):898-905. doi: 10.1016/s1359-6446(03)02832-0.
The solid form of a drug substance is important when developing a new chemical entity. The crystalline form used in development is significant based on possible manufacturability, solubility, bioavailability and stability differences between the solid forms. Regulatory issues require that the form present in a solid dosage form or liquids containing undissolved drug substance be identified. Drug product samples can be analyzed by a variety of techniques to determine the crystal form present or changes that occur during the manufacture of a drug product. The form present will affect development, regulatory and intellectual property issues.
在开发新化学实体时,药物物质的固体形态很重要。基于不同固体形态之间可能存在的可制造性、溶解度、生物利用度和稳定性差异,开发中使用的晶体形态具有重要意义。监管问题要求确定存在于固体剂型或含有未溶解药物物质的液体中的形态。药物产品样品可通过多种技术进行分析,以确定存在的晶体形态或药物产品制造过程中发生的变化。所存在的形态将影响开发、监管和知识产权问题。